NUWE .13 Plus! Big things are brewing behind the scenes. As per PR dated Nov. 3, 2022, Nuwellis Announced Peer Reviewed Data Demonstrating 71% Survival with Kidney Replacement Therapy Using a Modified Aquadex in Low-Birth-Weight Preterm Neonates
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.